Level and trend of total plasma cholesterol in national and subnational of Iran : a systematic review and age-spatio-temporal analysis from 1990 to 2016
© Springer Nature Switzerland AG 2022..
Purpose: We aimed to estimate the level and trend of plasma cholesterol and raised total cholesterol (TC > 200 mg/dl) prevalence at national and subnational level of Iran.
Methods: Nine national surveys and 27 studies, encompassing 3,505 unique points on over 500,000 adults, aged > 25 years with a report of laboratory measurement of TC were found. Age-spatio-temporal model and Gaussian Process Regression were used to estimate mean TC for each sex, 5-year age groups, and 31 provinces from 1990 to 2016.
Results: At national level, age-standardized prevalence of TC > 200 mg/dL has decreased from 57·2%(53·3-61·1) to 22·4%(20·5-24·3) in women and 53·2%(49·1-57·3) to 18·0%(16·4-19·6) in men. TC distribution presented a condensation between 170-200 mg/dL. At subnational level, decreasing and converging patterns of raised TC prevalence were detected.
Conclusion: The decrease in raised TC is likely the result of statin widespread use, food industry improvements, and the expanded primary health care.
Supplementary Information: The online version contains supplementary material available at 10.1007/s40200-022-01052-w.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:21 |
|---|---|
| Enthalten in: |
Journal of diabetes and metabolic disorders - 21(2022), 2 vom: 02. Dez., Seite 1301-1315 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Mehdipour, Parinaz [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Cholesterol |
|---|
| Anmerkungen: |
Date Revised 21.11.2022 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1007/s40200-022-01052-w |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM341906190 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM341906190 | ||
| 003 | DE-627 | ||
| 005 | 20231226012840.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s40200-022-01052-w |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1139.xml |
| 035 | |a (DE-627)NLM341906190 | ||
| 035 | |a (NLM)35668771 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Mehdipour, Parinaz |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Level and trend of total plasma cholesterol in national and subnational of Iran |b a systematic review and age-spatio-temporal analysis from 1990 to 2016 |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 21.11.2022 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a © Springer Nature Switzerland AG 2022. | ||
| 520 | |a Purpose: We aimed to estimate the level and trend of plasma cholesterol and raised total cholesterol (TC > 200 mg/dl) prevalence at national and subnational level of Iran | ||
| 520 | |a Methods: Nine national surveys and 27 studies, encompassing 3,505 unique points on over 500,000 adults, aged > 25 years with a report of laboratory measurement of TC were found. Age-spatio-temporal model and Gaussian Process Regression were used to estimate mean TC for each sex, 5-year age groups, and 31 provinces from 1990 to 2016 | ||
| 520 | |a Results: At national level, age-standardized prevalence of TC > 200 mg/dL has decreased from 57·2%(53·3-61·1) to 22·4%(20·5-24·3) in women and 53·2%(49·1-57·3) to 18·0%(16·4-19·6) in men. TC distribution presented a condensation between 170-200 mg/dL. At subnational level, decreasing and converging patterns of raised TC prevalence were detected | ||
| 520 | |a Conclusion: The decrease in raised TC is likely the result of statin widespread use, food industry improvements, and the expanded primary health care | ||
| 520 | |a Supplementary Information: The online version contains supplementary material available at 10.1007/s40200-022-01052-w | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Cholesterol | |
| 650 | 4 | |a Hypercholesterolemia | |
| 650 | 4 | |a Iran | |
| 650 | 4 | |a Longitudinal studies | |
| 650 | 4 | |a Prevalence | |
| 650 | 4 | |a Systematic review and meta-analysis | |
| 700 | 1 | |a Mohammadi, Esmaeil |e verfasserin |4 aut | |
| 700 | 1 | |a Sepanlou, Sadaf G |e verfasserin |4 aut | |
| 700 | 1 | |a Ahmadvand, Alireza |e verfasserin |4 aut | |
| 700 | 1 | |a Peykari, Niloofar |e verfasserin |4 aut | |
| 700 | 1 | |a Djalalinia, Shirin |e verfasserin |4 aut | |
| 700 | 1 | |a Rezaei-Darzi, Ehsan |e verfasserin |4 aut | |
| 700 | 1 | |a Mohebi, Farnam |e verfasserin |4 aut | |
| 700 | 1 | |a Moradi, Yousef |e verfasserin |4 aut | |
| 700 | 1 | |a Samaei, Mehrnoosh |e verfasserin |4 aut | |
| 700 | 1 | |a Khosravi, Ardeshir |e verfasserin |4 aut | |
| 700 | 1 | |a Jamshidi, Hamidreza |e verfasserin |4 aut | |
| 700 | 1 | |a Farzadfar, Farshad |e verfasserin |4 aut | |
| 700 | 0 | |a NASBOD Risk Collaborating Group |e verfasserin |4 aut | |
| 700 | 1 | |a Azizi, Fereydoun |e investigator |4 oth | |
| 700 | 1 | |a Khalili, Davood |e investigator |4 oth | |
| 700 | 1 | |a Khoshnia, Masoud |e investigator |4 oth | |
| 700 | 1 | |a Kouhpayehzadeh, Jalil |e investigator |4 oth | |
| 700 | 1 | |a Malekzadeh, Reza |e investigator |4 oth | |
| 700 | 1 | |a Merat, Shahin |e investigator |4 oth | |
| 700 | 1 | |a Mirzazadeh, Ali |e investigator |4 oth | |
| 700 | 1 | |a Mohammad, Kazem |e investigator |4 oth | |
| 700 | 1 | |a Mohammadifard, Noushin |e investigator |4 oth | |
| 700 | 1 | |a Nabipour, Iraj |e investigator |4 oth | |
| 700 | 1 | |a Parsaeian, Mahboubeh |e investigator |4 oth | |
| 700 | 1 | |a Pourshams, Akram |e investigator |4 oth | |
| 700 | 1 | |a Poustchi, Hossein |e investigator |4 oth | |
| 700 | 1 | |a Sarrafzadegan, Nizal |e investigator |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of diabetes and metabolic disorders |d 2012 |g 21(2022), 2 vom: 02. Dez., Seite 1301-1315 |w (DE-627)NLM225847558 |x 2251-6581 |7 nnns |
| 773 | 1 | 8 | |g volume:21 |g year:2022 |g number:2 |g day:02 |g month:12 |g pages:1301-1315 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s40200-022-01052-w |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 21 |j 2022 |e 2 |b 02 |c 12 |h 1301-1315 | ||